Information Journal Paper
APA:
CopyAZMANDIAN, J., RAHIMI, N., SOHREVARDI, S.M., ETMINAN, A., FAZELI, F., AZIZISHOUL, S., & SHAFII, Z.. (2013). EVALUATION OF LONG-TERM EFFECT OF ADDING LOW-DOSE DACLIZUMAB TO STANDARD PROTOCOL ON KIDNEY REJECTION IN KIDNEY RECIPIENTS. JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES, 20(5), 425-434. SID. https://sid.ir/paper/61/en
Vancouver:
CopyAZMANDIAN J., RAHIMI N., SOHREVARDI S.M., ETMINAN A., FAZELI F., AZIZISHOUL S., SHAFII Z.. EVALUATION OF LONG-TERM EFFECT OF ADDING LOW-DOSE DACLIZUMAB TO STANDARD PROTOCOL ON KIDNEY REJECTION IN KIDNEY RECIPIENTS. JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2013;20(5):425-434. Available from: https://sid.ir/paper/61/en
IEEE:
CopyJ. AZMANDIAN, N. RAHIMI, S.M. SOHREVARDI, A. ETMINAN, F. FAZELI, S. AZIZISHOUL, and Z. SHAFII, “EVALUATION OF LONG-TERM EFFECT OF ADDING LOW-DOSE DACLIZUMAB TO STANDARD PROTOCOL ON KIDNEY REJECTION IN KIDNEY RECIPIENTS,” JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES, vol. 20, no. 5, pp. 425–434, 2013, [Online]. Available: https://sid.ir/paper/61/en